In patients undergoing electrophysiology procedures, programmed threshold testing for internal cardioverter and defibrillator (ICD) insertion involves testing of the apparatus and repeated inductions of ventricular fibrillation (VF), which can result in global cerebral hypoperfusion similar to cardiac arrest.
To the Editor,
In patients undergoing electrophysiology procedures, programmed threshold testing for internal cardioverter and defibrillator (ICD) insertion involves testing of the apparatus and repeated inductions of ventricular fibrillation (VF), which can result in global cerebral hypoperfusion similar to cardiac arrest. 1 Hypercapnia is known to increase cerebral blood flow (CBF) and cerebral vasodilation. The adjustment of ventilation to raise cerebral regional saturation (rSO 2 ) is a common intervention in correcting brain desaturation and part of a previously reported and validated algorithm. 2 Preliminary evidence has shown that hypoventilation (with resulting hypercarbia) may prevent cerebral desaturations during ICD insertion and cardiac arrest. 3 It is possible that deeper sedation with increased hypoventilation and hypercapnia may increase CBF to compensate for decreases in cardiac output associated with VF and reduce the risk of cerebral desaturation. The use of near-infrared spectroscopy (NIRS) to monitor and prevent brain desaturation by pre-emptively increasing CBF has not been reported. The purpose of this study is to test the effectiveness of permissive sedation-induced hypercapnia in decreasing the severity of cerebral desaturation episodes during ICD insertion.
This randomized-controlled study was approved (03-2009 #03-076) by the Montreal Heart Institute ethics review board. After informed consent, all patients undergoing ICD insertion were sedated with remifentanil and propofol and randomized in two groups: a ''light sedation'' (LS) and a ''deep sedation'' (DS) group. Monitoring using NIRS and blood gases was performed in both groups. The VF test was induced via preprogrammed electrical stimulations. The primary endpoint was a reduction in episodes of significant cerebral desaturation in the group with permissive hypercapnia. Unfortunately, the trial was stopped before completion because, unexpectedly, recommendations were made to avoiding testing the defibrillators. 4 A total of 13 (out of 20) patients were recruited for the study with six LS and six DS patients and one exclusion. On average, patients were older in the LS than DS group (69 yr vs 58 yr) and more frequently males (LS: six males; DS: two males/four females). The DS group had lower mean (standard deviation Note that patient in the DS group (B) had a proportionally higher area over the baseline cerebral regional saturation (rSO 2 ) value compared with an LS patient (A) before VF, which was associated with a reduction in the cerebral rSO 2 value, but it only fell below the rSO 2 baseline in the LS group. Patients C and D had reduced ejection fractions \ 30% with a baseline rSO 2 below 60%. Note that the DS patient (D) had a significantly higher area over the baseline cerebral rSO 2 value compared with the LS patient (C). Ventricular fibrillation was associated with a reduction in cerebral rSO 2 values in both patients, but it only fell below the rSO 2 baseline in the LS group These observations are pertinent for the increased role of NIRS in cardiac arrest 5 suggesting that patients with good resuscitation outcomes have significantly higher NIRS values. Deeper sedation and consequently a higher PaCO 2 value increase rSO 2 and may attenuate the reduction in rSO 2 and consequently cerebral blood flow during VF.
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